<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27746555</article-id><article-id pub-id-type="pmc">5062219</article-id><article-id pub-id-type="publisher-id">AER-10-580</article-id><article-id pub-id-type="doi">10.4103/0259-1162.183564</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A comparative study of esmolol and dexmedetomidine on hemodynamic responses to carbon dioxide pneumoperitoneum during laparoscopic surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>Dhurjoti Prosad</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Saha</surname><given-names>Sauvik</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Paul</surname><given-names>Sanjib</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Roychowdhary</surname><given-names>Shibsankar</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Mondal</surname><given-names>Shirsendu</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Paul</surname><given-names>Suhrita</given-names></name><xref ref-type="aff" rid="aff3">2</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1">Department of Anaesthesiology, Calcutta National Medical College, Kolkata, West Bengal, India</aff><aff id="aff2"><label>1</label>Department of General Surgery, Calcutta National Medical College, Kolkata, West Bengal, India</aff><aff id="aff3"><label>2</label>Department of Pharmacology, Medical College, Kolkata, West Bengal, India</aff><author-notes><corresp id="cor1">
Corresponding author: Dr. Suhrita Paul, Department of Pharmacology, Medical College, Kolkata, FE-149, Sector III, Salt Lake City, Kolkata - 700 106, West Bengal, India. E-mail: <email xlink:href="drsuhritapaul@yahoo.co.in">drsuhritapaul@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Dec</season><year>2016</year></pub-date><volume>10</volume><issue>3</issue><fpage>580</fpage><lpage>584</lpage><permissions><copyright-statement>Copyright: &#x000a9; Anesthesia: Essays and Researches</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Carbon dioxide pneumoperitoneum for laparoscopic surgery increases arterial pressures, heart rate (HR), and systemic vascular resistance. In this randomized, single-blind, placebo-controlled clinical study, we investigated and compared the efficacy of esmolol and dexmedetomidine to provide perioperative hemodynamic stability in patients undergoing laparoscopic cholecystectomy.</p></sec><sec id="st2"><title>Methods:</title><p>Sixty patients, of either sex undergoing elective laparoscopic cholecystectomy, were randomly allocated into three groups containing twenty patients each. Group E received bolus dose of 500 &#x003bc;g/kg intravenous (IV) esmolol before pneumoperitoneum followed by an infusion of 100 &#x003bc;g/kg/min. Group D received bolus dose of 1 &#x003bc;g/kg IV dexmedetomidine before pneumoperitoneum followed by infusion of 0.2 &#x003bc;g/kg/h. Group S (control) received saline 0.9%.</p></sec><sec id="st3"><title>Results:</title><p>Mean arterial pressure and HR in Group E and D were significantly less throughout the period of pneumoperitoneum in comparison to Group S. IV nitroglycerine was required in 45% (9 out of 20) patients in Group S to control intraoperative hypertension, and it was clinically significant in comparison to Group E and D.</p></sec><sec id="st4"><title>Conclusion:</title><p>Both esmolol and dexmedetomidine attenuate the adverse hemodynamic response to pneumoperitoneum and provide hemodynamic stability during laparoscopic surgery.</p></sec></abstract><kwd-group><kwd>Dexmedetomidine</kwd><kwd>esmolol</kwd><kwd>hemodynamics</kwd><kwd>laparoscopic surgery</kwd><kwd>pneumoperitoneum</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Carbon dioxide (CO<sub>2</sub>) is commonly used to create pneumoperitoneum for laparoscopic surgical procedures.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Both CO<sub>2</sub> and pneumoperitoneum cause adverse cardiovascular effects.[<xref rid="ref3" ref-type="bibr">3</xref>] Adverse cardiovascular changes are characterized by elevation of arterial pressure and systemic vascular resistance and decreased cardiac output.[<xref rid="ref4" ref-type="bibr">4</xref>] These hemodynamic responses are mainly due to increased release of catecholamines, vasopressin, or both.[<xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>] Attenuation of adverse hemodynamic response to pneumoperitoneum is usually done by opioids,[<xref rid="ref7" ref-type="bibr">7</xref>] vasodilators,[<xref rid="ref8" ref-type="bibr">8</xref>] and &#x003b1;<sub>2</sub> adrenergic agonists.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>]</p><p>Esmolol, an ultrashort-acting cardioselective &#x003b2;<sub>1</sub> adrenoceptor antagonist, has been used to control tachycardia and hypertension. Esmolol blunts adrenergic responses to perioperative noxious stimuli effectively.[<xref rid="ref11" ref-type="bibr">11</xref>] Koivusalo <italic>et al</italic>.[<xref rid="ref12" ref-type="bibr">12</xref>] have shown that esmolol is effective in attenuating the adverse hemodynamic response to CO<sub>2</sub> pneumoperitoneum.[<xref rid="ref12" ref-type="bibr">12</xref>]</p><p>Dexmedetomidine, an &#x003b1;<sub>2</sub> adrenergic receptor agonist, possesses hypnotic, sedative, anxiolytic, sympatholytic, and analgesic properties without producing significant respiratory depression.[<xref rid="ref13" ref-type="bibr">13</xref>] Its sympatholytic effect decreases mean arterial pressure (MAP) and heart rate (HR) by reducing norepinephrine release.[<xref rid="ref14" ref-type="bibr">14</xref>] Bhattacharjee <italic>et al</italic>.[<xref rid="ref10" ref-type="bibr">10</xref>] have shown that dexmedetomidine is effective in attenuating the adverse hemodynamic response to CO<sub>2</sub> pneumoperitoneum.[<xref rid="ref10" ref-type="bibr">10</xref>]</p><p>In this study, the researchers wanted to compare the efficacy of esmolol and dexmedetomidine administered before pneumoperitoneum to attenuate the adverse hemodynamic response to laparoscopic surgery.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>The study protocol was approved by the Institutional Ethics Committee, and informed consent was obtained from the individual patients. Sixty American Society of Anesthesiologists&#x02019; (ASA) Grade I and II patients, aged 20&#x02013;60 years, undergoing elective laparoscopic cholecystectomy under general anesthesia were randomly assigned to one of the three groups of 20 patients each: Group E (esmolol group), Group D (dexmedetomidine group), and Group S (control group). Power calculations suggested that a minimum of 17 subjects per group were required to detect 10% difference in arterial pressure between groups (<italic>a</italic> = 0.05, <italic>b</italic> = 0.80) to accommodate the probable dropouts, a number of twenty patients in each group were included in the study. Patients in whom surgery could not be completed laparoscopically and open cholecystectomy done were excluded from the study.</p><p>Patients with preexisting hypertension, bronchial asthma, diabetes, sinus bradycardia, and severe hepatic, renal, endocrine and cardiac dysfunction were excluded from the study. Patients were then randomly allocated (using computer-derived random number sequence) into three groups (<italic>n</italic> = 20) to receive one of the following regimens: Group E received bolus dose of 500 &#x000b5;g/kg intravenous (IV) esmolol before pneumoperitoneum followed by an infusion of 100 &#x000b5;g/kg/min. Group D received bolus dose of 1 &#x000b5;g/kg IV dexmedetomidine before pneumoperitoneum followed by infusion of 0.2 &#x000b5;g/kg/h. Group S received saline 0.9%.</p><p>All the patients were given diazepam 10 mg and ranitidine 150 mg orally on the night before surgery and tablet ranitidine was repeated on the morning of surgery. On arrival to operation theater, routine ASA monitoring (electrocardiography, pulse oximetry, and noninvasive blood pressure) was started and baseline vital parameters, for example, HR, MAP, and arterial oxygen saturation were recorded. An IV line was started. Patients were induced with fentanyl 2 &#x000b5;g/kg and propofol 2 mg/kg intravenously (IV). Endotracheal intubation was facilitated by muscle relaxant rocuronium 0.7 mg/kg. Anesthesia was maintained with 33% O<sub>2</sub> in N<sub>2</sub>O, 0.6% isoflurane, and intermittent bolus dose of rocuronium. Patients received additional doses of fentanyl 1 &#x000b5;g/kg (IV) at half hourly intervals. Group E patients received bolus dose of 500 &#x000b5;g/kg IV esmolol before pneumoperitoneum followed by an infusion of 100 &#x000b5;g/kg/min. Group D received bolus dose of 1 &#x000b5;g/kgIV dexmedetomidine before pneumoperitoneum followed by infusion of 0.2 &#x000b5;g/kg/h and those allocated in Group S received 0.9% saline. CO<sub>2</sub> was insufflated into the peritoneal cavity to create pneumoperitoneum. Intra-abdominal pressure (IAP) was maintained up to 12 mmHg throughout the laparoscopic procedure. All the patients were positioned in a head-up tilt of 15&#x000b0;. The patients were mechanically ventilated to keep end-tidal CO<sub>2</sub> between 35 and 45 mmHg. Injection paracetamol 1000 mg was infused IV in every patient.</p><p>In cases of acute and severe hemodynamic fluctuations, the following medical interventions were taken:</p><p>
<list list-type="roman-lower"><list-item><p>Bradycardia (HR &#x0003c;60 beats/min), bolus dose of 0.6 mg atropine IV;</p></list-item><list-item><p>Hypotension (MAP &#x0003c;60 mmHg), increased rate of infusion of IV fluid, and/or bolus dose of phenylephrine 100 mcg IV and;</p></list-item><list-item><p>Hypertension (MAP &#x0003e;110 mmHg) nitroglycerine infusion IV.</p></list-item></list>
</p><p>At the end of the surgery, ondansetron 4 mg was administered IV for prophylaxis against nausea and vomiting. Residual neuromuscular block was reversed with appropriate doses of neostigmine and glycopyrrolate, and tracheal extubation was performed. HR and MAP were recorded at the following points of time:</p><p>
<list list-type="order"><list-item><p>Baseline</p></list-item><list-item><p>3 min after endotracheal intubation</p></list-item><list-item><p>Before pneumoperitoneum</p></list-item><list-item><p>10 min after pneumoperitoneum</p></list-item><list-item><p>20 min after pneumoperitoneum</p></list-item><list-item><p>30 min after pneumoperitoneum</p></list-item><list-item><p>40 min after pneumoperitoneum</p></list-item><list-item><p>50 min after pneumoperitoneum</p></list-item><list-item><p>After release of pneumoperitoneum</p></list-item><list-item><p>After extubation.</p></list-item></list>
</p><p>Patients were observed for adverse events, for example, bradycardia, hypotension, and hypertension during postoperative period in postanesthesia care unit.</p><sec id="sec2-1"><title>Statistical analysis</title><p>The numerical data obtained from the study were expressed as mean &#x000b1; standard deviation comparison between groups were performed with Kruskal&#x02013;Wallis one-way analysis of variance by ranks or Fisher's exact test for small samples with a 5% risk. Mann&#x02013;Whitney&#x02013;Wilcoxon tests were performed when normality tests failed (GraphPad InStat, version 3.05, GraphPad Software, San Diego, CA, USA).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>The patients allocated into the Group E, Group D, and Group S was comparable with respect to age, distribution of gender, body weight, and the duration of surgery [<xref ref-type="table" rid="T1">Table 1</xref>]. No significant difference was found regarding the preoperative MAP and the MA<italic>P</italic> values following intubation and before pneumoperitoneum among all three groups (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="table" rid="T2">Table 2</xref>]. However, following pneumoperitoneum, MA<italic>P</italic> values in Group E and Group D were significantly lower compared to Group S at 10, 20, 30, 40, and 50 min after pneumoperitoneum, following the release of CO<sub>2</sub> and after extubation (<italic>P</italic> &#x0003c; 0.05) [<xref ref-type="table" rid="T2">Table 2</xref>]. On comparing patients in Group E and Group D, no significant difference in MAP was found at any time interval.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Patient's characteristics and duration of surgery (mean&#x000b1;SD)</p></caption><graphic xlink:href="AER-10-580-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Changes in mean arterial pressure</p></caption><graphic xlink:href="AER-10-580-g002"/></table-wrap><p>Similarly, no significant difference was found between the preoperative HR, and the HR values following intubation and before pneumoperitoneum among all three groups (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="table" rid="T2">Table 2</xref>]. However, following pneumoperitoneum, HR values in Group E and Group D were significantly lower compared to Group S at 10, 20, 30, 40, and 50 min after pneumoperitoneum, following the release of CO<sub>2</sub> and after extubation (<italic>P</italic> &#x0003c; 0.05) [<xref ref-type="table" rid="T3">Table 3</xref>]. On comparing patients in Group E and Group D, no significant difference in HR was found at any time interval.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Changes in heart rate (mean&#x000b1;SD)</p></caption><graphic xlink:href="AER-10-580-g003"/></table-wrap><p>Three patients of Group E and two patients of Group D suffered from bradycardia in our study, but the incidences are not statistically significant [<xref ref-type="table" rid="T4">Table 4</xref>]. Hypertension occurred in nine patients (45%) of Group S, whereas no patients of Group E and D suffered from hypertension. There was no incidence of hypotension in any group [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Distribution of patients according to adverse effects. Values are in number</p></caption><graphic xlink:href="AER-10-580-g004"/></table-wrap><p>When the groups were compared for the parameters of recovery-extubation time, response to verbal commands, and time for orientation, there were no significant differences among the groups (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="table" rid="T5">Table 5</xref>].</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Recovery time (minutes) (mean&#x000b1;SD)</p></caption><graphic xlink:href="AER-10-580-g005"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>In the study, we observed and compared the effects of esmolol and dexmedetomidine, administered before pneumoperitoneum, on hemodynamics in patients undergoing laparoscopic cholecystectomy.</p><p>In laparoscopic surgery, CO<sub>2</sub> is routinely used to create pneumoperitoneum.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Immediately after pneumoperitoneum, plasma levels of catecholamines and vasopressin are increased. Increased catecholamine level activates the renin-angiotensin-aldosterone-system leading to some of the characteristic hemodynamic alterations such as elevated arterial pressure and increased systemic/pulmonary vascular resistance.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] Vasopressin also contributes to elevation of arterial pressure by increasing the systemic vascular resistance.[<xref rid="ref6" ref-type="bibr">6</xref>] Drugs such as &#x003b1;<sub>2</sub> adrenergic agonists[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] and magnesium sulfate[<xref rid="ref15" ref-type="bibr">15</xref>] have been successfully used for attenuating the rise in MAP and HR in response to pneumoperitoneum during laparoscopic surgery.</p><p>Esmolol is an ultrashort-acting cardioselective &#x003b2;<sub>1</sub> adrenoceptor antagonist and is found effective to attenuate adrenergic responses to perioperative noxious stimuli.[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref16" ref-type="bibr">16</xref>] Esmolol has been successfully used for tracheal intubation,[<xref rid="ref17" ref-type="bibr">17</xref>] maintenance of anesthesia,[<xref rid="ref16" ref-type="bibr">16</xref>] and emergence from anesthesia and extubation.[<xref rid="ref11" ref-type="bibr">11</xref>] It has been also used to blunt pressor and HR response to noxious stimuli. The hemodynamic effects of esmolol are thought to be mediated by blockade of peripheral beta-adrenergic receptors. Koivusalo <italic>et al</italic>.[<xref rid="ref12" ref-type="bibr">12</xref>] have used esmolol in an initial bolus of 1 mg/kg before pneumoperitoneum and followed by an infusion of 200 &#x000b5;g/kg/min. They observed that esmolol was effective in attenuating the rise of HR and arterial pressure during laparoscopic surgery.[<xref rid="ref12" ref-type="bibr">12</xref>] In our institution, we tried the similar doses of esmolol (both bolus and infusion), but we found that incidence of bradycardia was too high to be acceptable. The recommended bolus dose of esmolol varies between 250 &#x000b5;g/kg and 1 mg/kg and infusion ranges from 50 to 300 &#x000b5;g/kg/min. Hence, in our study, we used bolus dose of 500 &#x000b5;g/kg IV esmolol before pneumoperitoneum followed by an infusion of 100 &#x000b5;g/kg/min and still found that the dose was effective.</p><p>Dexmedetomidine is an &#x003b1;<sub>2</sub> adrenergic receptor agonist having hypnotic, sedative, anxiolytic, sympatholytic, and analgesic properties without producing significant respiratory depression.[<xref rid="ref13" ref-type="bibr">13</xref>] Activation of receptors in the brain and spinal cord level inhibits neuronal firing, thereby causing hypotension, bradycardia, sedation, and analgesia.[<xref rid="ref18" ref-type="bibr">18</xref>] Presynaptic activation of &#x003b1;<sub>2</sub> adrenergic receptors inhibits the release of norepinephrine. Postsynaptic activation of &#x003b1;<sub>2</sub> adrenergic receptors inhibits sympathetic outflow and therefore decrease blood pressure and HR.[<xref rid="ref19" ref-type="bibr">19</xref>] Dexmedetomidine does not appear to have any direct effect on heart.[<xref rid="ref20" ref-type="bibr">20</xref>] Bhattacharjee <italic>et al</italic>.[<xref rid="ref10" ref-type="bibr">10</xref>] have used dexmedetomidine in a bolus dose of 1 &#x000b5;g/kg IV before pneumoperitoneum followed by infusion of 0.2 &#x000b5;g/kg/h; they found that dexmedetomidine is effective in attenuating the adverse hemodynamic response to CO<sub>2</sub> pneumoperitoneum.[<xref rid="ref10" ref-type="bibr">10</xref>] In our study, we administered that dose of dexmedetomidine to the patients of Group D.</p><p>In our study, baseline MAP and MAP after intubation and before pneumoperitoneum was comparable between the three groups. However, MAP was significantly lower throughout the period of CO<sub>2</sub> pneumoperitoneum and after extubation in patients of Group E and Group D compared to patients of Group S. We observed the similar finding in the case of HR also. Hence, both esmolol and dexmedetomidine administered intravenously before and during pneumoperitoneum were effective in attenuating the increase in MAP and HR during CO<sub>2</sub> pneumoperitoneum.</p><p>Diamant <italic>et al</italic>.[<xref rid="ref21" ref-type="bibr">21</xref>] reported 35% decrease in cardiac output in dogs with a raised IAP of 40 mmHg. Ishizaki <italic>et al</italic>.[<xref rid="ref22" ref-type="bibr">22</xref>] tried to evaluate the safe IAP during laparoscopic surgery. They observed significant fall in cardiac output at 16 mmHg of IAP and hemodynamic alterations were much less at 12 mmHg of IAP. Hence, in our study, we kept IAP 12 mmHg. In spite of maintaining normocapnia and keeping IAP 12 mmHg, there was a significant rise of MAP and HR in patients of Group S during pneumoperitoneum. However, in Group E and D, hemodynamic responses to pneumoperitoneum were effectively blunted, and both the MAP and HR were remained at a significantly lower level compared to Group S. Recovery times are comparable in all the groups.</p><p>As far as the adverse effects are concerned, no patient of either group suffered from hypotension and bradycardia in our study. Hypertension occurred in nine patients (45%) of Group S for which they had to be treated with nitroglycerin infusion, whereas no patient of Group E and D suffered from hypertension.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Both esmolol and dexmedetomidine effectively attenuates the elevation of MAP and HR during and after pneumoperitoneum and thereby provides hemodynamic stability during laparoscopic surgery. There is no significant difference between the efficacy of esmolol and dexmedetomidine regarding the attenuation of hemodynamic response to pneumoperitoneum to laparoscopic surgery.</p><sec id="sec2-2"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-3"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>C</given-names></name><name><surname>McClelland</surname><given-names>RM</given-names></name><name><surname>Newton</surname><given-names>JR</given-names></name></person-group><article-title>Some effects of the peritoneal insufflation of carbon dioxide at laparoscopy</article-title><source>Anaesthesia</source><year>1970</year><volume>25</volume><fpage>382</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">4246974</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blobner</surname><given-names>M</given-names></name><name><surname>Felber</surname><given-names>AR</given-names></name><name><surname>Gogler</surname><given-names>S</given-names></name></person-group><article-title>Carbon-dioxide uptake from the pneumoperitoneum during laparoscopic cholecystectomy</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>A37</fpage><lpage>40</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>JD</given-names></name><name><surname>Trinkle</surname><given-names>JK</given-names></name></person-group><article-title>Hemodynamic and respiratory alterations with increased intra-abdominal pressure</article-title><source>J Surg Res</source><year>1976</year><volume>20</volume><fpage>401</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">933497</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>RJ</given-names></name><name><surname>Thomas</surname><given-names>TA</given-names></name><name><surname>Wilkins</surname><given-names>DG</given-names></name></person-group><article-title>Cardiovascular changes during laparoscopy. Studies of stroke volume and cardiac output using impedance cardiography</article-title><source>Anaesthesia</source><year>1976</year><volume>31</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">130811</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myre</surname><given-names>K</given-names></name><name><surname>Rostrup</surname><given-names>M</given-names></name><name><surname>Buanes</surname><given-names>T</given-names></name><name><surname>Stokland</surname><given-names>O</given-names></name></person-group><article-title>Plasma catecholamines and haemodynamic changes during pneumoperitoneum</article-title><source>Acta Anaesthesiol Scand</source><year>1998</year><volume>42</volume><fpage>343</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9542563</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walder</surname><given-names>AD</given-names></name><name><surname>Aitkenhead</surname><given-names>AR</given-names></name></person-group><article-title>Role of vasopressin in the haemodynamic response to laparoscopic cholecystectomy</article-title><source>Br J Anaesth</source><year>1997</year><volume>78</volume><fpage>264</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9135302</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lentschener</surname><given-names>C</given-names></name><name><surname>Axler</surname><given-names>O</given-names></name><name><surname>Fernandez</surname><given-names>H</given-names></name><name><surname>Megarbane</surname><given-names>B</given-names></name><name><surname>Billard</surname><given-names>V</given-names></name><name><surname>Fouqueray</surname><given-names>B</given-names></name><etal/></person-group><article-title>Haemodynamic changes and vasopressin release are not consistently associated with carbon dioxide pneumoperitoneum in humans</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>527</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">11308999</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joris</surname><given-names>JL</given-names></name><name><surname>Hamoir</surname><given-names>EE</given-names></name><name><surname>Hartstein</surname><given-names>GM</given-names></name><name><surname>Meurisse</surname><given-names>MR</given-names></name><name><surname>Hubert</surname><given-names>BM</given-names></name><name><surname>Charlier</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma</article-title><source>Anesth Analg</source><year>1999</year><volume>88</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">9895059</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joris</surname><given-names>JL</given-names></name><name><surname>Chiche</surname><given-names>JD</given-names></name><name><surname>Canivet</surname><given-names>JL</given-names></name><name><surname>Jacquet</surname><given-names>NJ</given-names></name><name><surname>Legros</surname><given-names>JJ</given-names></name><name><surname>Lamy</surname><given-names>ML</given-names></name></person-group><article-title>Hemodynamic changes induced by laparoscopy and their endocrine correlates: Effects of clonidine</article-title><source>J Am Coll Cardiol</source><year>1998</year><volume>32</volume><fpage>1389</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">9809953</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharjee</surname><given-names>DP</given-names></name><name><surname>Nayak</surname><given-names>SK</given-names></name><name><surname>Dawn</surname><given-names>S</given-names></name><name><surname>Bandyopadhyay</surname><given-names>G</given-names></name><name><surname>Gupta</surname><given-names>K</given-names></name></person-group><article-title>Effects of dexmedetomidine on haemodynamics in patients undergoing laparoscopic cholecystectomy-a comparative study</article-title><source>J Anaesth Pharmacol</source><year>2010</year><volume>26</volume><fpage>45</fpage><lpage>8</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrman</surname><given-names>TM</given-names></name><name><surname>Ewell</surname><given-names>CL</given-names></name><name><surname>Pippin</surname><given-names>WD</given-names></name><name><surname>Weaver</surname><given-names>JM</given-names></name></person-group><article-title>Comparison of the efficacy of esmolol and alfentanil to attenuate the hemodynamic responses to emergence and extubation</article-title><source>J Clin Anesth</source><year>1992</year><volume>4</volume><fpage>444</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1360803</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koivusalo</surname><given-names>AM</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name><name><surname>Tikkanen</surname><given-names>I</given-names></name><name><surname>Yli-Suomu</surname><given-names>T</given-names></name><name><surname>Ristkari</surname><given-names>S</given-names></name><name><surname>Laakso</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effects of esmolol on haemodynamic response to CO2 pneumoperitoneum for laparoscopic surgery</article-title><source>Acta Anaesthesiol Scand</source><year>1998</year><volume>42</volume><fpage>510</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9605365</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Uhrich</surname><given-names>TD</given-names></name><name><surname>Barney</surname><given-names>JA</given-names></name><name><surname>Arain</surname><given-names>SR</given-names></name><name><surname>Ebert</surname><given-names>TJ</given-names></name></person-group><article-title>Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions</article-title><source>Anesth Analg</source><year>2000</year><volume>90</volume><fpage>699</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">10702460</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guler</surname><given-names>G</given-names></name><name><surname>Akin</surname><given-names>A</given-names></name><name><surname>Tosun</surname><given-names>Z</given-names></name><name><surname>Eskitascoglu</surname><given-names>E</given-names></name><name><surname>Mizrak</surname><given-names>A</given-names></name><name><surname>Boyaci</surname><given-names>A</given-names></name></person-group><article-title>Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation</article-title><source>Acta Anaesthesiol Scand</source><year>2005</year><volume>49</volume><fpage>1088</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16095449</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Yun</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name></person-group><article-title>Magnesium sulphate attenuates arterial pressure increase during laparoscopic cholecystectomy</article-title><source>Br J Anaesth</source><year>2009</year><volume>103</volume><fpage>484</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19617379</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MI</given-names></name><name><surname>Sacks</surname><given-names>DJ</given-names></name><name><surname>Grosnoff</surname><given-names>DB</given-names></name><name><surname>Herrington</surname><given-names>C</given-names></name><name><surname>Skillman</surname><given-names>CA</given-names></name></person-group><article-title>Use of esmolol during anesthesia to treat tachycardia and hypertension</article-title><source>Anesth Analg</source><year>1989</year><volume>68</volume><fpage>101</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">2563314</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vucevic</surname><given-names>M</given-names></name><name><surname>Purdy</surname><given-names>GM</given-names></name><name><surname>Ellis</surname><given-names>FR</given-names></name></person-group><article-title>Esmolol hydrochloride for management of the cardiovascular stress responses to laryngoscopy and tracheal intubation</article-title><source>Br J Anaesth</source><year>1992</year><volume>68</volume><fpage>529</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">1642945</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>TZ</given-names></name><name><surname>Jiang</surname><given-names>JY</given-names></name><name><surname>Buttermann</surname><given-names>AE</given-names></name><name><surname>Maze</surname><given-names>M</given-names></name></person-group><article-title>Dexmedetomidine injection into the locus ceruleus produces antinociception</article-title><source>Anesthesiology</source><year>1996</year><volume>84</volume><fpage>873</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8638842</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnbaumer</surname><given-names>L</given-names></name><name><surname>Abramowitz</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>AM</given-names></name></person-group><article-title>Receptor-effector coupling by G proteins</article-title><source>Biochim Biophys Acta</source><year>1990</year><volume>1031</volume><fpage>163</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">2160274</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Housmans</surname><given-names>PR</given-names></name></person-group><article-title>Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium</article-title><source>Anesthesiology</source><year>1990</year><volume>73</volume><fpage>919</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">1978616</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamant</surname><given-names>M</given-names></name><name><surname>Benumof</surname><given-names>JL</given-names></name><name><surname>Saidman</surname><given-names>LJ</given-names></name></person-group><article-title>Hemodynamics of increased intra-abdominal pressure: Interaction with hypovolemia and halothane anesthesia</article-title><source>Anesthesiology</source><year>1978</year><volume>48</volume><fpage>23</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">619705</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizaki</surname><given-names>Y</given-names></name><name><surname>Bandai</surname><given-names>Y</given-names></name><name><surname>Shimomura</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>H</given-names></name><name><surname>Ohtomo</surname><given-names>Y</given-names></name><name><surname>Idezuki</surname><given-names>Y</given-names></name></person-group><article-title>Safe intraabdominal pressure of CO2 pneumoperitoneum during laparoscopic surgery</article-title><source>Surgery</source><year>1993</year><volume>114</volume><fpage>549</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">8367810</pub-id></element-citation></ref></ref-list></back></article>